{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T08:31:08Z","timestamp":1786523468541,"version":"build-2736575974"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T00:00:00Z","timestamp":1786492800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T00:00:00Z","timestamp":1786492800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100015077","name":"Wydzia\u0142 Lekarski, Uniwersytet Jagiello\u0144ski Collegium Medicum","doi-asserted-by":"publisher","award":["N41\/DBS\/000506"],"award-info":[{"award-number":["N41\/DBS\/000506"]}],"id":[{"id":"10.13039\/100015077","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Res Cardiol"],"DOI":"10.1007\/s00392-026-02987-3","type":"journal-article","created":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T07:52:55Z","timestamp":1786521175000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Vascular endothelial dysfunction and echocardiographic changes in male and female patients with Fabry disease: a single-center observational study"],"prefix":"10.1007","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0321-3557","authenticated-orcid":false,"given":"Rados\u0142aw","family":"Dziedzic","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2031-6657","authenticated-orcid":false,"given":"Piotr","family":"Kuszmiersz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-8686-8905","authenticated-orcid":false,"given":"Magdalena","family":"Szu\u015bcik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-5556-2637","authenticated-orcid":false,"given":"Anna","family":"Drynda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4889-2218","authenticated-orcid":false,"given":"Magdalena","family":"Celi\u0144ska-L\u00f6wenhoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6492-6521","authenticated-orcid":false,"given":"Agnieszka","family":"Padjas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6535-4841","authenticated-orcid":false,"given":"Renata","family":"Pacholczak-Madej","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2221-614X","authenticated-orcid":false,"given":"Lech","family":"Zar\u0119ba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9738-7007","authenticated-orcid":false,"given":"Jan G.","family":"Bazan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9634-0963","authenticated-orcid":false,"given":"Stanis\u0142awa","family":"Bazan-Socha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0768-5597","authenticated-orcid":false,"given":"Jerzy","family":"Dropi\u0144ski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,12]]},"reference":[{"issue":"2","key":"2987_CR1","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1007\/s11897-024-00645-1","volume":"21","author":"D Weissman","year":"2024","unstructured":"Weissman D, Dudek J, Sequeira V, Maack C (2024) Fabry disease: cardiac implications and molecular mechanisms. Curr Heart Fail Rep 21(2):81\u2013100. https:\/\/doi.org\/10.1007\/s11897-024-00645-1","journal-title":"Curr Heart Fail Rep"},{"issue":"1","key":"2987_CR2","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/1750-1172-5-30","volume":"5","author":"DP Germain","year":"2010","unstructured":"Germain DP (2010) Fabry disease. Orphanet J Rare Dis 5(1):30. https:\/\/doi.org\/10.1186\/1750-1172-5-30","journal-title":"Orphanet J Rare Dis"},{"issue":"1","key":"2987_CR3","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1111\/cge.12613","volume":"89","author":"L Echevarria","year":"2016","unstructured":"Echevarria L et al (2016) X\u2010chromosome inactivation in female patients with Fabry disease. Clin Genet 89(1):44\u201354. https:\/\/doi.org\/10.1111\/cge.12613","journal-title":"Clin Genet"},{"issue":"4","key":"2987_CR4","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1016\/j.ymgme.2018.02.014","volume":"123","author":"A Ortiz","year":"2018","unstructured":"Ortiz A et al (2018) Fabry disease revisited: management and treatment recommendations for adult patients. Mol Genet Metab 123(4):416\u2013427. https:\/\/doi.org\/10.1016\/j.ymgme.2018.02.014","journal-title":"Mol Genet Metab"},{"issue":"suppl 1","key":"2987_CR5","doi-asserted-by":"publisher","first-page":"s10","DOI":"10.1590\/1806-9282.66.s1.10","volume":"66","author":"TP Bernardes","year":"2020","unstructured":"Bernardes TP, Foresto RD, Kirsztajn GM (2020) Fabry disease: genetics, pathology, and treatment. Rev Assoc Med Bras 66(suppl 1):s10\u2013s16. https:\/\/doi.org\/10.1590\/1806-9282.66.s1.10","journal-title":"Rev Assoc Med Bras"},{"issue":"2","key":"2987_CR6","doi-asserted-by":"publisher","first-page":"271","DOI":"10.3390\/biom11020271","volume":"11","author":"K Kok","year":"2021","unstructured":"Kok K, Zwiers KC, Boot RG, Overkleeft HS, Aerts JMFG, Artola M (2021) Fabry disease: molecular basis, pathophysiology, diagnostics and potential therapeutic directions. Biomolecules 11(2):271. https:\/\/doi.org\/10.3390\/biom11020271","journal-title":"Biomolecules"},{"issue":"9647","key":"2987_CR7","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1016\/S0140-6736(08)61589-5","volume":"372","author":"YA Zarate","year":"2008","unstructured":"Zarate YA, Hopkin RJ (2008) Fabry\u2019s disease. Lancet 372(9647):1427\u20131435. https:\/\/doi.org\/10.1016\/S0140-6736(08)61589-5","journal-title":"Lancet"},{"issue":"FI2","key":"2987_CR8","doi-asserted-by":"publisher","first-page":"f153","DOI":"10.1093\/europace\/eux261","volume":"20","author":"S Baig","year":"2018","unstructured":"Baig S et al (2018) Ventricular arrhythmia and sudden cardiac death in Fabry disease: a systematic review of risk factors in clinical practice. EP Europace 20(FI2):f153\u2013f161. https:\/\/doi.org\/10.1093\/europace\/eux261","journal-title":"EP Europace"},{"issue":"11","key":"2987_CR9","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1097\/GIM.0b013e3181bb05bb","volume":"11","author":"S Waldek","year":"2009","unstructured":"Waldek S, Patel MR, Banikazemi M, Lemay R, Lee P (2009) Life expectancy and cause of death in males and females with Fabry disease: findings from the fabry registry. Genet Med 11(11):790\u2013796. https:\/\/doi.org\/10.1097\/GIM.0b013e3181bb05bb","journal-title":"Genet Med"},{"issue":"15","key":"2987_CR10","doi-asserted-by":"publisher","first-page":"8273","DOI":"10.3390\/ijms25158273","volume":"25","author":"DC Faro","year":"2024","unstructured":"Faro DC, Di Pino FL, Monte IP (2024) Inflammation, oxidative stress, and endothelial dysfunction in the pathogenesis of vascular damage: unraveling novel cardiovascular risk factors in fabry disease. Int J Mol Sci 25(15):8273. https:\/\/doi.org\/10.3390\/ijms25158273","journal-title":"Int J Mol Sci"},{"issue":"4","key":"2987_CR11","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1016\/j.pharep.2015.05.010","volume":"67","author":"M Frolow","year":"2015","unstructured":"Frolow M, Drozdz A, Kowalewska A, Nizankowski R, Chlopicki S (2015) Comprehensive assessment of vascular health in patients; towards endothelium-guided therapy. Pharmacol Rep 67(4):786\u2013792. https:\/\/doi.org\/10.1016\/j.pharep.2015.05.010","journal-title":"Pharmacol Rep"},{"issue":"4","key":"2987_CR12","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1016\/j.pharep.2015.06.008","volume":"67","author":"M Walczak","year":"2015","unstructured":"Walczak M, Suraj J, Kus K, Kij A, Zakrzewska A, Chlopicki S (2015) Towards a comprehensive endothelial biomarkers profiling and endothelium-guided pharmacotherapy. Pharmacol Rep 67(4):771\u2013777. https:\/\/doi.org\/10.1016\/j.pharep.2015.06.008","journal-title":"Pharmacol Rep"},{"issue":"2","key":"2987_CR13","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1161\/01.ATV.0000051384.43104.FC","volume":"23","author":"PO Bonetti","year":"2003","unstructured":"Bonetti PO, Lerman LO, Lerman A (2003) Endothelial dysfunction: a marker of atherosclerotic risk. ATVB 23(2):168\u2013175. https:\/\/doi.org\/10.1161\/01.ATV.0000051384.43104.FC","journal-title":"ATVB"},{"issue":"6","key":"2987_CR14","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1161\/01.CIR.0000028581.07992.56","volume":"106","author":"JA Vita","year":"2002","unstructured":"Vita JA, Keaney JF (2002) Endothelial function: a barometer for cardiovascular risk? Circulation 106(6):640\u2013642. https:\/\/doi.org\/10.1161\/01.CIR.0000028581.07992.56","journal-title":"Circulation"},{"issue":"3","key":"2987_CR15","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1161\/HYPERTENSIONAHA.110.167015","volume":"57","author":"DJ Green","year":"2011","unstructured":"Green DJ, Jones H, Thijssen D, Cable NT, Atkinson G (2011) Flow-mediated dilation and cardiovascular event prediction: does nitric oxide matter? Hypertension 57(3):363\u2013369. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.110.167015","journal-title":"Hypertension"},{"issue":"1\u20132","key":"2987_CR16","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.jns.2014.06.029","volume":"344","author":"R El-Abassi","year":"2014","unstructured":"El-Abassi R, Singhal D, England JD (2014) Fabry\u2019s disease. J Neurol Sci 344(1\u20132):5\u201319. https:\/\/doi.org\/10.1016\/j.jns.2014.06.029","journal-title":"J Neurol Sci"},{"issue":"9","key":"2987_CR17","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22094434","volume":"22","author":"O Azevedo","year":"2021","unstructured":"Azevedo O et al (2021) Fabry disease and the heart: a comprehensive review. Int J Mol Sci 22(9):4434. https:\/\/doi.org\/10.3390\/ijms22094434","journal-title":"Int J Mol Sci"},{"issue":"7","key":"2987_CR18","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1016\/j.jacc.2020.12.024","volume":"77","author":"M Pieroni","year":"2021","unstructured":"Pieroni M et al (2021) Cardiac involvement in fabry disease. J Am Coll Cardiol 77(7):922\u2013936. https:\/\/doi.org\/10.1016\/j.jacc.2020.12.024","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"2987_CR19","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1016\/j.echo.2018.01.016","volume":"31","author":"DF Yeung","year":"2018","unstructured":"Yeung DF et al (2018) Echocardiographic assessment of patients with fabry disease. J Am Soc Echocardiogr 31(6):639-649.e2. https:\/\/doi.org\/10.1016\/j.echo.2018.01.016","journal-title":"J Am Soc Echocardiogr"},{"key":"2987_CR20","doi-asserted-by":"publisher","unstructured":"Kottam A et al (2023) State-of-the-art imaging of infiltrative cardiomyopathies: a scientific statement from the American Heart Association. Circ: Cardiovasc Imag 16(11). https:\/\/doi.org\/10.1161\/HCI.0000000000000081","DOI":"10.1161\/HCI.0000000000000081"},{"issue":"S451","key":"2987_CR21","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1111\/j.1651-2227.2006.tb02392.x","volume":"95","author":"F Barbey","year":"2006","unstructured":"Barbey F et al (2006) Increased carotid intima\u2013media thickness in the absence of atherosclerotic plaques in an adult population with Fabry disease. Acta Paediatr 95(S451):63\u201368. https:\/\/doi.org\/10.1111\/j.1651-2227.2006.tb02392.x","journal-title":"Acta Paediatr"},{"issue":"30","key":"2987_CR22","doi-asserted-by":"publisher","first-page":"2534","DOI":"10.1093\/eurheartj\/ehz350","volume":"40","author":"DHJ Thijssen","year":"2019","unstructured":"Thijssen DHJ et al (2019) Expert consensus and evidence-based recommendations for the assessment of flow-mediated dilation in humans. Eur Heart J 40(30):2534\u20132547. https:\/\/doi.org\/10.1093\/eurheartj\/ehz350","journal-title":"Eur Heart J"},{"issue":"5","key":"2987_CR23","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1177\/0003319720981521","volume":"72","author":"AC Vujkovac","year":"2021","unstructured":"Vujkovac AC, Vujkovac B, Novakovi\u0107 S, \u0160tevanec M, \u0160abovi\u010d M (2021) Characteristics of vascular phenotype in fabry patients. Angiology 72(5):426\u2013433. https:\/\/doi.org\/10.1177\/0003319720981521","journal-title":"Angiology"},{"issue":"5","key":"2987_CR24","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1007\/s10545-006-0340-x","volume":"29","author":"RJ Kalliokoski","year":"2006","unstructured":"Kalliokoski RJ et al (2006) Structural and functional changes in peripheral vasculature of Fabry patients. J of Inher Metab Disea 29(5):660\u2013666. https:\/\/doi.org\/10.1007\/s10545-006-0340-x","journal-title":"J of Inher Metab Disea"},{"issue":"4","key":"2987_CR25","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1161\/HYPERTENSIONAHA.112.195685","volume":"60","author":"SM Rombach","year":"2012","unstructured":"Rombach SM et al (2012) Vascular aspects of Fabry disease in relation to clinical manifestations and elevations in plasma globotriaosylsphingosine. Hypertension 60(4):998\u20131005. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.112.195685","journal-title":"Hypertension"},{"issue":"1","key":"2987_CR26","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1007\/s10545-013-9607-1","volume":"37","author":"L Costanzo","year":"2014","unstructured":"Costanzo L et al (2014) Early cardiovascular remodelling in Fabry disease. J Inherit Metab Dis 37(1):109\u2013116. https:\/\/doi.org\/10.1007\/s10545-013-9607-1","journal-title":"J Inherit Metab Dis"},{"issue":"9","key":"2987_CR27","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1136\/jmg.38.9.629","volume":"38","author":"P Boutouyrie","year":"2001","unstructured":"Boutouyrie P (2001) Non-invasive evaluation of arterial involvement in patients affected with Fabry disease. J Med Genet 38(9):629\u2013631. https:\/\/doi.org\/10.1136\/jmg.38.9.629","journal-title":"J Med Genet"},{"issue":"3","key":"2987_CR28","first-page":"295","volume":"24","author":"D Puccio","year":"2005","unstructured":"Puccio D et al (2005) Non invasive evaluation of endothelial function in patients with Anderson-Fabry disease. Int Angiol 24(3):295\u2013299","journal-title":"Int Angiol"},{"issue":"8828","key":"2987_CR29","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1016\/0140-6736(92)93147-F","volume":"340","author":"DS Celermajer","year":"1992","unstructured":"Celermajer DS et al (1992) Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet 340(8828):1111\u20131115. https:\/\/doi.org\/10.1016\/0140-6736(92)93147-F","journal-title":"Lancet"},{"issue":"8","key":"2987_CR30","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11082263","volume":"11","author":"J Dropi\u0144ski","year":"2022","unstructured":"Dropi\u0144ski J et al (2022) Central retinal artery occlusion is related to vascular endothelial injury and left ventricular diastolic dysfunction. J Clin Med 11(8):2263. https:\/\/doi.org\/10.3390\/jcm11082263","journal-title":"J Clin Med"},{"issue":"7505","key":"2987_CR31","doi-asserted-by":"publisher","first-page":"1432","DOI":"10.1136\/bmj.330.7505.1432","volume":"330","author":"GS Hillis","year":"2005","unstructured":"Hillis GS, Bloomfield P (2005) Basic transthoracic echocardiography. BMJ 330(7505):1432\u20131436. https:\/\/doi.org\/10.1136\/bmj.330.7505.1432","journal-title":"BMJ"},{"issue":"1","key":"2987_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.echo.2018.06.004","volume":"32","author":"C Mitchell","year":"2019","unstructured":"Mitchell C et al (2019) Guidelines for performing a comprehensive transthoracic echocardiographic examination in adults: recommendations from the american society of echocardiography. J Am Soc Echocardiogr 32(1):1\u201364. https:\/\/doi.org\/10.1016\/j.echo.2018.06.004","journal-title":"J Am Soc Echocardiogr"},{"issue":"10","key":"2987_CR33","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1111\/j.1440-1681.2008.04984.x","volume":"35","author":"JL Park","year":"2008","unstructured":"Park JL, Whitesall SE, D\u2019Alecy LG, Shu L, Shayman JA (2008) Vascular dysfunction in the \u03b1-galactosidase a-knockout mouse is an endothelial cell-, plasma membrane-based defect. Clin Exp Pharma Physio 35(10):1156\u20131163. https:\/\/doi.org\/10.1111\/j.1440-1681.2008.04984.x","journal-title":"Clin Exp Pharma Physio"},{"issue":"20","key":"2987_CR34","doi-asserted-by":"publisher","first-page":"2453","DOI":"10.3390\/cells12202453","volume":"12","author":"I Mirza","year":"2023","unstructured":"Mirza I et al (2023) Adiposomes from obese-diabetic individuals promote endothelial dysfunction and loss of surface caveolae. Cells 12(20):2453. https:\/\/doi.org\/10.3390\/cells12202453","journal-title":"Cells"},{"issue":"6","key":"2987_CR35","doi-asserted-by":"publisher","first-page":"H3043","DOI":"10.1152\/ajpheart.00190.2006","volume":"291","author":"BA Parker","year":"2006","unstructured":"Parker BA, Ridout SJ, Proctor DN (2006) Age and flow-mediated dilation: a comparison of dilatory responsiveness in the brachial and popliteal arteries. Am J Physiol Heart Circ Physiol 291(6):H3043\u2013H3049. https:\/\/doi.org\/10.1152\/ajpheart.00190.2006","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"2987_CR36","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.ijcard.2020.09.029","volume":"324","author":"M Kajikawa","year":"2021","unstructured":"Kajikawa M et al (2021) Association of body mass index with endothelial function in asian men. Int J Cardiol 324:186\u2013192. https:\/\/doi.org\/10.1016\/j.ijcard.2020.09.029","journal-title":"Int J Cardiol"},{"issue":"1","key":"2987_CR37","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/j.ijcard.2012.09.047","volume":"168","author":"RT Ras","year":"2013","unstructured":"Ras RT, Streppel MT, Draijer R, Zock PL (2013) Flow-mediated dilation and cardiovascular risk prediction: a systematic review with meta-analysis. Int J Cardiol 168(1):344\u2013351. https:\/\/doi.org\/10.1016\/j.ijcard.2012.09.047","journal-title":"Int J Cardiol"},{"key":"2987_CR38","doi-asserted-by":"publisher","unstructured":"Ishizu T et al (2004) Effect of age on carotid arterial intima-media thickness in childhood. Heart Vess 19(4). https:\/\/doi.org\/10.1007\/s00380-004-0766-8","DOI":"10.1007\/s00380-004-0766-8"},{"issue":"4","key":"2987_CR39","doi-asserted-by":"publisher","first-page":"917","DOI":"10.5336\/medsci.2012-30163","volume":"33","author":"E Altuno\u011flu","year":"2013","unstructured":"Altuno\u011flu E et al (2013) Carotid intima media thickness and parameters related to blood flow in obese patients. Turk Klinikleri J Med Sci 33(4):917\u2013922. https:\/\/doi.org\/10.5336\/medsci.2012-30163","journal-title":"Turk Klinikleri J Med Sci"},{"issue":"3","key":"2987_CR40","doi-asserted-by":"publisher","first-page":"101600","DOI":"10.1016\/j.ancard.2023.101600","volume":"72","author":"N Mahoungou-Mackonia","year":"2023","unstructured":"Mahoungou-Mackonia N et al (2023) Les maladies cardiovasculaires chez les jeunes patients\u202f: place de l\u2019\u00e9paisseur intima-m\u00e9dia carotidienne au CHU-Ibn Rochd de Casablanca. Annales de Cardiologie et d\u2019Ang\u00e9iologie 72(3):101600. https:\/\/doi.org\/10.1016\/j.ancard.2023.101600","journal-title":"Annales de Cardiologie et d\u2019Ang\u00e9iologie"},{"issue":"3","key":"2987_CR41","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1213\/ANE.0000000000004478","volume":"130","author":"P Duque","year":"2020","unstructured":"Duque P, Mora L, Levy JH, Sch\u00f6chl H (2020) Pathophysiological response to trauma-induced coagulopathy: a comprehensive review. Anesth Analg 130(3):654\u2013664. https:\/\/doi.org\/10.1213\/ANE.0000000000004478","journal-title":"Anesth Analg"},{"issue":"9","key":"2987_CR42","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1016\/j.echo.2011.05.021","volume":"24","author":"M Niemann","year":"2011","unstructured":"Niemann M et al (2011) Tei index in Fabry disease. J Am Soc Echocardiogr 24(9):1026\u20131032. https:\/\/doi.org\/10.1016\/j.echo.2011.05.021","journal-title":"J Am Soc Echocardiogr"},{"issue":"10","key":"2987_CR43","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1093\/eurheartj\/ehm153","volume":"28","author":"A Linhart","year":"2007","unstructured":"Linhart A et al (2007) Cardiac manifestations of Anderson-Fabry disease: results from the international Fabry outcome survey. Eur Heart J 28(10):1228\u20131235. https:\/\/doi.org\/10.1093\/eurheartj\/ehm153","journal-title":"Eur Heart J"},{"issue":"1","key":"2987_CR44","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1146\/annurev-med-090910-085119","volume":"62","author":"F Weidemann","year":"2011","unstructured":"Weidemann F, Niemann M, Warnock DG, Ertl G, Wanner C (2011) The Fabry cardiomyopathy: models for the cardiologist. Annu Rev Med 62(1):59\u201367. https:\/\/doi.org\/10.1146\/annurev-med-090910-085119","journal-title":"Annu Rev Med"},{"issue":"3","key":"2987_CR45","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.ymgme.2008.06.016","volume":"95","author":"J-S Shen","year":"2008","unstructured":"Shen J-S et al (2008) Globotriaosylceramide induces oxidative stress and up-regulates cell adhesion molecule expression in Fabry disease endothelial cells. Mol Genet Metab 95(3):163\u2013168. https:\/\/doi.org\/10.1016\/j.ymgme.2008.06.016","journal-title":"Mol Genet Metab"},{"issue":"10","key":"2987_CR46","doi-asserted-by":"publisher","first-page":"5158","DOI":"10.3390\/ijms25105158","volume":"25","author":"G Duro","year":"2024","unstructured":"Duro G et al (2024) Diagnosis of Fabry disease using alpha-galactosidase a activity or lysogb3 in blood fails to identify up to two thirds of female patients. Int J Mol Sci 25(10):5158. https:\/\/doi.org\/10.3390\/ijms25105158","journal-title":"Int J Mol Sci"},{"issue":"3","key":"2987_CR47","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1016\/j.ymgme.2011.05.008","volume":"104","author":"U Feldt-Rasmussen","year":"2011","unstructured":"Feldt-Rasmussen U et al (2011) Diagnostic dilemma: a young woman with Fabry disease symptoms, no family history, and a \u2018sequencing cryptic\u2019 \u03b1-galactosidase a large deletion. Mol Genet Metab 104(3):314\u2013318. https:\/\/doi.org\/10.1016\/j.ymgme.2011.05.008","journal-title":"Mol Genet Metab"},{"issue":"4","key":"2987_CR48","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0036373","volume":"7","author":"M Namdar","year":"2012","unstructured":"Namdar M et al (2012) Globotriaosylsphingosine accumulation and not alpha-galactosidase-A deficiency causes endothelial dysfunction in Fabry disease. PLoS ONE 7(4):e36373. https:\/\/doi.org\/10.1371\/journal.pone.0036373","journal-title":"PLoS ONE"},{"issue":"10","key":"2987_CR49","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.2215\/CJN.0000000000000239","volume":"18","author":"SJ Van Der Veen","year":"2023","unstructured":"Van Der Veen SJ et al (2023) Early risk stratification for natural disease course in Fabry patients using plasma globotriaosylsphingosine levels. Clin J Am Soc Nephrol 18(10):1272\u20131282. https:\/\/doi.org\/10.2215\/CJN.0000000000000239","journal-title":"Clin J Am Soc Nephrol"},{"issue":"3","key":"2987_CR50","doi-asserted-by":"publisher","DOI":"10.1002\/jimd.70034","volume":"48","author":"R Schiffmann","year":"2025","unstructured":"Schiffmann R (2025) Role of biomarkers in diagnosing disease, assessing the severity and progression of disease, and evaluating the efficacy of therapies. J Inherit Metab Dis 48(3):e70034. https:\/\/doi.org\/10.1002\/jimd.70034","journal-title":"J Inherit Metab Dis"}],"container-title":["Clinical Research in Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00392-026-02987-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00392-026-02987-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00392-026-02987-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T07:52:57Z","timestamp":1786521177000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00392-026-02987-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,12]]},"references-count":50,"alternative-id":["2987"],"URL":"https:\/\/doi.org\/10.1007\/s00392-026-02987-3","relation":{},"ISSN":["1861-0684","1861-0692"],"issn-type":[{"value":"1861-0684","type":"print"},{"value":"1861-0692","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,12]]},"assertion":[{"value":"22 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}